Evidence map›Paper›PMID 28904002›Full record

ReviewJournal of the American Society of Nephrology : JASN2017

Assessing Microvascular Function in Humans from a Chronic Disease Perspective.

Alfons J H M Houben, Remy J H Martens, Coen D A Stehouwer

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Journal of the American Society of Nephrology : JASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07240103 (Blood-Interstitial Fluid Glucose Gap), which is not on this map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07240103 completednot on this mapstarted 2023, after this paper: background citation

Blood-Interstitial Fluid Glucose Gap: A Novel Indicator for Assessing Metabolic Status and Mortality Risk in Critically Ill Patients

Typeobservational_patient_registrySponsorChinese Medical AssociationRan2023 to 2025Enrolled140ConditionsCritical Illness, Metabolism Disorders
3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 136 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Dietary supplementation with whey protein improves systemic microvascular function in heart failure patients: a pilot study.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2021
    Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alfons J H M HoubenDepartment of Internal Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands; and b.houben@maastrichtuniversity.nl.
Remy J H MartensDepartment of Internal Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands; and.
Coen D A StehouwerDepartment of Internal Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands; and.
Maastricht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microvascular dysfunction (MVD) is considered a crucial pathway in the development and progression of cardiometabolic and renal disease and is associated with increased cardiovascular mortality. MVD often coexists with or even precedes macrovascular disease, possibly due to shared mechanisms of vascular damage, such as inflammatory processes and oxidative stress. One of the first events in MVD is endothelial dysfunction. With the use of different physiologic or pharmacologic stimuli, endothelium-dependent (micro)vascular reactivity can be studied. This reactivity depends on the balance between various mediators, including nitric oxide, endothelin, and prostanoids, among others. The measurement of microvascular (endothelial) function is important to understand the pathophysiologic mechanisms that contribute to MVD and the role of MVD in the development and progression of cardiometabolic/renal disease. Here, we review a selection of direct, noninvasive techniques for measuring human microcirculation, with a focus on methods, interpretation, and limitations from the perspective of chronic cardiometabolic and renal disease.

Indexed as

MicrocirculationAgingCapillariesCardiovascular DiseasesChronic DiseaseDisease ProgressionEndothelinsEndothelium, VascularHumansInfant, Low Birth WeightInflammationKidney DiseasesKidney Failure, ChronicLaser-Doppler FlowmetryMicroscopyNitric OxideEndothelinsNitric OxideProstaglandinsCardiometabolic diseaseendotheliumMicrovascular dysfunctionPathophysiologyRenal disease

Identifiers

PMID28904002
PMCPMC5698072
OpenAlexW2756082575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.